Decitabine
- Product NDC
- 70860-219
- 11-digit product format
- 708600219
- Labeler code
- 70860
- Product ID
- 70860-219_c0e96668-282d-4675-ab52-6dd6fe37b5d5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- decitabine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA212826
- Marketing category
- ANDA
- Marketing start
- 2021-08-15
- Marketing end
- 0000-00-00
- Substance
- DECITABINE
- Active strength
- 50 mg/20mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-219-20 | 70860021920 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-219-20) > 20 mL in 1 VIAL, SINGLE-DOSE | 2021-08-15 | 0000-00-00 | No | No | Current |